Shruti Daga - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Shruti Daga

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of the American Heart Association|June 18, 2013

Cardiovascular effects of a novel SIRT1 activator, SRT2104, in otherwise healthy cigarette smokersSowmya Venkatasubramanian, Radzi Mohd Noh, Shruti Daga, et al.

Nature Cancer|October 3, 2025

Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemiaCarl Sandén, Niklas Landberg, Pablo Peña-Martínez, et al.

British Journal of Clinical Pharmacology|November 13, 2021

A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid-targeted bromodomain and extra-terminal domain inhibitorJack A Brown, Joanne Bal, Monica Simeoni, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of the American Heart Association|June 18, 2013

Cardiovascular effects of a novel SIRT1 activator, SRT2104, in otherwise healthy cigarette smokersSowmya Venkatasubramanian, Radzi Mohd Noh, Shruti Daga, et al.

Nature Cancer|October 3, 2025

Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemiaCarl Sandén, Niklas Landberg, Pablo Peña-Martínez, et al.

British Journal of Clinical Pharmacology|November 13, 2021

A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid-targeted bromodomain and extra-terminal domain inhibitorJack A Brown, Joanne Bal, Monica Simeoni, et al.

Pageof 2